Pharma Journalist -

SMi reports: Associate Director at ProQR is set to present at the 10th Annual RNA Therapeutics Conference, taking place on 20th – 21st February 2019 in London. Undoubtedly, the field…
Read More...

GlaxoSmithKline plc announced that it has successfully completed the acquisition of TESARO, Inc. an oncology-focused company based in Waltham, Massachusetts, for an aggregate cash…
Read More...

Vertex Pharmaceuticals (Europe) Limited announced that the European Commission has granted approval of the label extension for ORKAMBI (lumacaftor/ivacaftor) for the treatment of…
Read More...

Alnylam Pharmaceuticals and Medison Pharma announced an exclusive agreement to commercialize ONPATTRO, the first-ever commercialized RNAi therapeutic, as well as other investigational…
Read More...

Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved ONTRUZANT (trastuzumab-dttb), a biosimilar referencing HERCEPTIN (trastuzumab), across…
Read More...

The Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) today voted eight to eight on the question of whether the overall benefits of…
Read More...

Pharma Regulatory Summit is the leading platform for regulatory experts, to be updated with latest country updates and strategies to navigate the complex and ever changing regulations…
Read More...

SMi Reports: Biotech Genentech, discoverers of a promising new antibiotic, are set to speak at this year’s Superbugs & Superdrugs Conference in London, UK on 18th - 19th March 2019.…
Read More...

SMi reports: As the 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference returns to London in May 2019, industry professionals are set to discuss overcoming the latest…
Read More...

AstraZeneca announced that its partner Ironwood Pharmaceuticals, Inc. has received marketing authorisation from the National Medical Products Administration (NMPA) for Linzess…
Read More...